Unknown

Dataset Information

Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter.


ABSTRACT: High expression and phosphorylation of signal transducer and transcription activator 3 (STAT3) are correlated with progression and poor prognosis in various types of cancer. The constitutive activation of STAT3 in cancer affects processes such as cell proliferation, apoptosis, metastasis, angiogenesis, and drug resistance. The importance of STAT3 in cancer makes it a potential therapeutic target. Various methods of directly and indirectly blocking STAT3 activity at different steps of the STAT3 pathway have been investigated. However, the outcome has been limited, mainly by the number of upstream proteins that can reactivate STAT3 or the relatively low specificity of the inhibitors. A new branch of molecules with significant therapeutic potential has emerged thanks to recent developments in

SUBMITTER: Molenda S 

PROVIDER: S-EPMC10705165 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature